img
img
Intravitreal bevacizumab for diabetic papillopathy      
Yazarlar (2)
Prof. Dr. Kemal ÖRNEK Prof. Dr. Kemal ÖRNEK
Kırıkkale Üniversitesi, Türkiye
Tevfik Oğurel
Kırıkkale Üniversitesi, Türkiye
Devamını Göster
Özet
A 43-year-old woman presented with a visual acuity of 1/10 in the right eye and 3/10 in the left eye. Ophthalmologic examination disclosed optic disc swelling on both sides with mild nonproliferative diabetic retinopathy. The pupils were equal and reactive without an afferent pupillary defect. Visual field testing showed no significant defect in both eyes. Systemic investigations revealed no abnormality. The patient was injected with bevacizumab intravitreally with the diagnosis of diabetic papillopathy (DP). Three weeks later, the vision increased to 7/10 in the right eye and optic disc edema disappeared. Intravitreal injection of bevacizumab effectively treated DP.
Anahtar Kelimeler
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayımlanan tam makale
Dergi Adı JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
Dergi ISSN 1080-7683 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI
Makale Dili İngilizce
Basım Tarihi 04-2010
Cilt No 26
Sayı 2
Sayfalar 217 / 218
Doi Numarası 10.1089/jop.2009.0125
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
WoS 10
SCOPUS 12
Google Scholar 25
Intravitreal bevacizumab for diabetic papillopathy

Paylaş